Advertisement
Screener

UTAH MEDICAL PRODUCTS, INC. (UTMD) Gross Profit

UTAH MEDICAL PRODUCTS, INC. Gross Profit

UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Gross Profit of $4.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Income Statement

us-gaap:GrossProfit · last filed 2026-08-12

  • UTAH MEDICAL PRODUCTS, INC. gross profit for the quarter ending 2026-06-30 was $4.76M, a 14.96% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. gross profit for the quarter ending 2026-03-31 was $5.28M, a 4.62% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. gross profit for the quarter ending 2025-12-31 was $5.26M, a 1.11% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. gross profit for the quarter ending 2025-09-30 was $5.60M, a 3.41% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. gross profit for fiscal 2025 was $22.00M, a 8.87% decline from fiscal 2024.
  • UTAH MEDICAL PRODUCTS, INC. gross profit for fiscal 2024 was $24.14M, a 19.63% decline from fiscal 2023.
  • UTAH MEDICAL PRODUCTS, INC. gross profit for fiscal 2023 was $30.04M, a 6.70% decline from fiscal 2022.
  • UTAH MEDICAL PRODUCTS, INC. gross profit for fiscal 2022 was $32.20M, a 4.14% increase from fiscal 2021.
Period endGross Profit 3 monthGross Profit 6 monthGross Profit 9 monthGross Profit 12 month
2026-06-30$4.76M
10-Q · filed 2026-08-12
$10.04M
10-Q · filed 2026-08-12
$15.30M
derived: sum of 3 quarters · filed 2026-08-12
$20.91M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$5.28M
10-Q · filed 2026-05-12
$10.55M
derived: sum of 2 quarters · filed 2026-05-12
$16.15M
derived: sum of 3 quarters · filed 2026-05-12
$21.75M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$5.26M
10-K · filed 2026-03-27
$10.87M
derived: sum of 2 quarters · filed 2026-03-27
$16.46M
derived: sum of 3 quarters · filed 2026-08-12
$22.00M
10-K · filed 2026-03-27
2025-09-30$5.60M
10-K · filed 2026-03-27
$11.20M
derived: sum of 2 quarters · filed 2026-08-12
$16.74M
10-Q · filed 2025-11-14
$22.06M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$5.59M
10-Q · filed 2026-08-12
$11.13M
10-Q · filed 2026-08-12
$16.46M
derived: sum of 3 quarters · filed 2026-08-12
$22.26M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$5.54M
10-Q · filed 2026-05-12
$10.86M
derived: sum of 2 quarters · filed 2026-05-12
$16.66M
derived: sum of 3 quarters · filed 2026-05-12
$22.92M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$5.32M
10-K · filed 2026-03-27
$11.13M
derived: sum of 2 quarters · filed 2026-03-27
$17.38M
derived: sum of 3 quarters · filed 2026-03-27
$24.14M
10-K · filed 2026-03-27
2024-09-30$5.80M
10-K · filed 2026-03-27
$12.05M
derived: sum of 2 quarters · filed 2026-03-27
$18.82M
10-Q · filed 2025-11-14
$25.92M
derived: sum of 4 quarters · filed 2026-03-27
2024-06-30$6.25M
10-K · filed 2026-03-27
$13.02M
10-Q · filed 2025-08-12
$20.12M
derived: sum of 3 quarters · filed 2026-03-27
$27.48M
derived: sum of 4 quarters · filed 2026-03-27
2024-03-31$6.77M
10-K · filed 2026-03-27
$13.86M
derived: sum of 2 quarters · filed 2026-03-27
$21.22M
derived: sum of 3 quarters · filed 2026-03-27
$28.96M
derived: sum of 4 quarters · filed 2026-03-27
2023-12-31$7.10M
10-K · filed 2026-03-27
$14.46M
derived: sum of 2 quarters · filed 2026-03-27
$22.20M
derived: sum of 3 quarters · filed 2026-03-27
$30.04M
10-K · filed 2026-03-27
2023-09-30$7.36M
10-K · filed 2026-03-27
$15.10M
derived: sum of 2 quarters · filed 2026-03-27
$22.94M
10-Q · filed 2024-11-12
$31.27M
derived: sum of 4 quarters · filed 2026-03-27
2023-06-30$7.74M
10-K · filed 2026-03-27
$15.58M
10-Q · filed 2024-08-09
$23.91M
derived: sum of 3 quarters · filed 2026-03-27
$32.09M
derived: sum of 4 quarters · filed 2026-03-27
2023-03-31$7.84M
10-K · filed 2026-03-27
$16.17M
derived: sum of 2 quarters · filed 2026-03-27
$24.36M
derived: sum of 3 quarters · filed 2026-03-27
$32.51M
derived: sum of 4 quarters · filed 2026-03-27
2022-12-31$8.33M
10-K · filed 2025-03-26
$16.51M
derived: sum of 2 quarters · filed 2025-03-26
$24.66M
derived: sum of 3 quarters · filed 2025-03-26
$32.20M
10-K · filed 2025-03-26
2022-09-30$8.19M
10-K · filed 2025-03-26
$16.34M
derived: sum of 2 quarters · filed 2025-03-26
$23.87M
10-Q · filed 2023-11-13
$31.98M
derived: sum of 4 quarters · filed 2025-03-26
2022-06-30$8.15M
10-K · filed 2025-03-26
$15.68M
10-Q · filed 2023-08-11
$23.80M
derived: sum of 3 quarters · filed 2025-03-26
$31.87M
derived: sum of 4 quarters · filed 2025-03-26
2022-03-31$7.53M
10-K · filed 2025-03-26
$15.64M
derived: sum of 2 quarters · filed 2025-03-26
$23.72M
derived: sum of 3 quarters · filed 2025-03-26
$31.50M
derived: sum of 4 quarters · filed 2025-03-26
2021-12-31$8.11M
10-K · filed 2024-03-26
$16.18M
derived: sum of 2 quarters · filed 2024-03-26
$23.97M
derived: sum of 3 quarters · filed 2024-03-26
$30.92M
10-K · filed 2024-03-26
2021-09-30$8.07M
10-K · filed 2024-03-26
$15.86M
derived: sum of 2 quarters · filed 2024-03-26
$22.80M
10-Q · filed 2022-11-10
$30.07M
derived: sum of 4 quarters · filed 2024-03-26
2021-06-30$7.79M
10-K · filed 2024-03-26
$14.73M
10-Q · filed 2022-08-12
$22.00M
derived: sum of 3 quarters · filed 2024-03-26
$28.49M
derived: sum of 4 quarters · filed 2024-03-26
2021-03-31$6.95M
10-K · filed 2024-03-26
$14.21M
derived: sum of 2 quarters · filed 2024-03-26
$20.71M
derived: sum of 3 quarters · filed 2024-03-26
$25.66M
derived: sum of 4 quarters · filed 2024-03-26
2020-12-31$7.26M
10-K/A · filed 2023-03-28
$13.76M
derived: sum of 2 quarters · filed 2023-03-28
$18.71M
derived: sum of 3 quarters · filed 2023-03-28
$25.55M
10-K/A · filed 2023-03-28
2020-09-30$6.50M
10-K/A · filed 2023-03-28
$11.45M
derived: sum of 2 quarters · filed 2023-03-28
$18.28M
10-Q · filed 2021-11-12
$26.10M
derived: sum of 4 quarters · filed 2023-03-28
2020-06-30$4.95M
10-K/A · filed 2023-03-28
$11.79M
10-Q · filed 2021-08-06
$19.60M
derived: sum of 3 quarters · filed 2023-03-28
$26.98M
derived: sum of 4 quarters · filed 2023-03-28
2020-03-31$6.84M
10-K/A · filed 2023-03-28
$14.65M
derived: sum of 2 quarters · filed 2023-03-28
$22.03M
derived: sum of 3 quarters · filed 2023-03-28
$29.53M
derived: sum of 4 quarters · filed 2023-03-28
2019-12-31$7.81M
10-K · filed 2022-03-25
$15.19M
derived: sum of 2 quarters · filed 2022-03-25
$22.69M
derived: sum of 3 quarters · filed 2022-03-25
$29.47M
10-K · filed 2022-03-25
2019-09-30$7.38M
10-K · filed 2022-03-25
$14.88M
derived: sum of 2 quarters · filed 2022-03-25
$21.65M
10-Q/A · filed 2020-11-09
$27.76M
derived: sum of 4 quarters · filed 2022-03-25
2019-06-30$7.50M
10-K · filed 2022-03-25
$14.27M
10-Q · filed 2020-08-07
$20.38M
derived: sum of 3 quarters · filed 2022-03-25
$26.67M
derived: sum of 4 quarters · filed 2022-03-25
2019-03-31$6.77M
10-K · filed 2022-03-25
$12.88M
derived: sum of 2 quarters · filed 2022-03-25
$19.17M
derived: sum of 3 quarters · filed 2022-03-25
$26.16M
derived: sum of 4 quarters · filed 2022-03-25
2018-12-31$6.11M
10-K · filed 2021-03-26
$12.40M
derived: sum of 2 quarters · filed 2021-03-26
$19.38M
derived: sum of 3 quarters · filed 2021-03-26
$26.31M
10-K · filed 2021-03-26
2018-09-30$6.29M
10-K · filed 2021-03-26
$13.28M
derived: sum of 2 quarters · filed 2021-03-26
$20.20M
10-Q · filed 2019-11-07
$26.67M
derived: sum of 4 quarters · filed 2021-03-26
2018-06-30$6.98M
10-K · filed 2021-03-26
$13.91M
10-Q · filed 2019-08-09
$20.38M
derived: sum of 3 quarters · filed 2021-03-26
$26.87M
derived: sum of 4 quarters · filed 2021-03-26
2018-03-31$6.92M
10-K · filed 2021-03-26
$13.39M
derived: sum of 2 quarters · filed 2021-03-26
$19.89M
derived: sum of 3 quarters · filed 2021-03-26
$26.78M
derived: sum of 4 quarters · filed 2021-03-26
2017-12-31$6.47M
10-K · filed 2020-03-16
$12.97M
derived: sum of 2 quarters · filed 2020-03-16
$19.86M
derived: sum of 3 quarters · filed 2020-03-16
$26.39M
10-K · filed 2020-03-16
2017-09-30$6.50M
10-K · filed 2020-03-16
$13.39M
derived: sum of 2 quarters · filed 2020-03-16
$19.93M
10-Q · filed 2018-11-07
$25.36M
derived: sum of 4 quarters · filed 2020-03-16
2017-06-30$6.89M
10-K · filed 2020-03-16
$13.43M
10-Q · filed 2018-08-09
$18.87M
derived: sum of 3 quarters · filed 2020-03-16
$24.64M
derived: sum of 4 quarters · filed 2020-03-16
2017-03-31$6.54M
10-K · filed 2020-03-16
$11.97M
derived: sum of 2 quarters · filed 2020-03-16
$17.75M
derived: sum of 3 quarters · filed 2020-03-16
$24.00M
derived: sum of 4 quarters · filed 2020-03-16
2016-12-31$5.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$11.21M
derived: sum of 2 quarters · filed 2019-03-14
$17.47M
derived: sum of 3 quarters · filed 2019-03-14
$23.69M
10-K · filed 2019-03-14
2016-09-30$5.78M
10-Q · filed 2017-11-07
$12.03M
derived: sum of 2 quarters · filed 2017-11-07
$18.25M
10-Q · filed 2017-11-07
$24.14M
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30$6.25M
10-Q · filed 2017-08-03
$12.47M
10-Q · filed 2017-08-03
$18.37M
derived: sum of 3 quarters · filed 2018-03-06
$24.45M
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31$6.22M
10-Q · filed 2017-05-05
$12.12M
derived: sum of 2 quarters · filed 2018-03-06
$18.20M
derived: sum of 3 quarters · filed 2018-03-06
$24.30M
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31$5.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$11.97M
derived: sum of 2 quarters · filed 2018-03-06
$18.07M
derived: sum of 3 quarters · filed 2018-03-06
$24.18M
10-K · filed 2018-03-06
2015-09-30$6.08M
10-Q · filed 2016-11-04
$12.18M
derived: sum of 2 quarters · filed 2016-11-04
$18.29M
10-Q · filed 2016-11-04
$24.68M
derived: sum of 4 quarters · filed 2017-03-08
2015-06-30$6.10M
10-Q · filed 2016-08-08
$12.21M
10-Q · filed 2016-08-08
$18.60M
derived: sum of 3 quarters · filed 2017-03-08
$24.80M
derived: sum of 4 quarters · filed 2017-03-08
2015-03-31$6.11M
10-Q · filed 2016-05-06
$12.50M
derived: sum of 2 quarters · filed 2017-03-08
$18.70M
derived: sum of 3 quarters · filed 2017-03-08
$25.05M
derived: sum of 4 quarters · filed 2017-03-08
2014-12-31$6.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08
$12.58M
derived: sum of 2 quarters · filed 2017-03-08
$18.93M
derived: sum of 3 quarters · filed 2017-03-08
$24.98M
10-K · filed 2017-03-08
2014-09-30$6.20M
10-Q · filed 2015-11-06
$12.54M
derived: sum of 2 quarters · filed 2015-11-06
$18.59M
10-Q · filed 2015-11-06
$24.59M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$6.35M
10-Q · filed 2015-08-07
$12.40M
10-Q · filed 2015-08-07
$18.39M
derived: sum of 3 quarters · filed 2016-03-10
$24.34M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$6.05M
10-Q · filed 2015-05-06
$12.04M
derived: sum of 2 quarters · filed 2016-03-10
$17.99M
derived: sum of 3 quarters · filed 2016-03-10
$24.04M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$5.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$11.94M
derived: sum of 2 quarters · filed 2016-03-10
$17.99M
derived: sum of 3 quarters · filed 2016-03-10
$24.27M
10-K · filed 2016-03-10
2013-09-30$5.95M
10-Q · filed 2014-11-04
$12.00M
derived: sum of 2 quarters · filed 2014-11-04
$18.28M
10-Q · filed 2014-11-04
$24.30M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$6.05M
10-Q · filed 2014-08-08
$12.33M
10-Q · filed 2014-08-08
$18.35M
derived: sum of 3 quarters · filed 2015-03-12
$24.83M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$6.28M
10-Q · filed 2014-05-07
$12.30M
derived: sum of 2 quarters · filed 2015-03-12
$18.78M
derived: sum of 3 quarters · filed 2015-03-12
$24.85M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$6.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$12.50M
derived: sum of 2 quarters · filed 2015-03-12
$18.57M
derived: sum of 3 quarters · filed 2015-03-12
$25.31M
10-K · filed 2015-03-12
2012-09-30$6.48M
10-Q · filed 2013-11-06
$12.55M
derived: sum of 2 quarters · filed 2013-11-06
$19.29M
10-Q · filed 2013-11-06
$25.20M
derived: sum of 4 quarters · filed 2014-03-12
2012-06-30$6.07M
10-Q · filed 2013-08-08
$12.81M
10-Q · filed 2013-08-08
$18.72M
derived: sum of 3 quarters · filed 2014-03-12
$25.24M
derived: sum of 4 quarters · filed 2014-03-12
2012-03-31$6.74M
10-Q · filed 2013-05-08
$12.65M
derived: sum of 2 quarters · filed 2014-03-12
$19.17M
derived: sum of 3 quarters · filed 2014-03-12
$25.43M
derived: sum of 4 quarters · filed 2014-03-12
2011-12-31$5.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12
$12.43M
derived: sum of 2 quarters · filed 2014-03-12
$18.69M
derived: sum of 3 quarters · filed 2014-03-12
$22.40M
10-K · filed 2014-03-12
2011-09-30$6.52M
10-Q · filed 2012-11-09
$12.78M
derived: sum of 2 quarters · filed 2012-11-09
$16.49M
10-Q · filed 2012-11-09
$19.77M
derived: sum of 4 quarters · filed 2013-03-07
2011-06-30$6.26M
10-Q · filed 2012-08-08
$9.97M
10-Q · filed 2012-08-08
$13.25M
derived: sum of 3 quarters · filed 2013-03-07
$16.59M
derived: sum of 4 quarters · filed 2013-03-07
2011-03-31$3.71M
10-Q · filed 2012-05-09
$6.99M
derived: sum of 2 quarters · filed 2013-03-07
$10.33M
derived: sum of 3 quarters · filed 2013-03-07
$13.60M
derived: sum of 4 quarters · filed 2013-03-07
2010-12-31$3.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07
$6.62M
derived: sum of 2 quarters · filed 2013-03-07
$9.89M
derived: sum of 3 quarters · filed 2013-03-07
$13.21M
10-K · filed 2013-03-07
2010-09-30$3.34M
10-Q · filed 2011-11-07
$6.60M
derived: sum of 2 quarters · filed 2011-11-07
$9.93M
10-Q · filed 2011-11-07
2010-06-30$3.27M
10-Q · filed 2011-08-08
$6.59M
10-Q · filed 2011-08-08
2009-12-31$13.79M
10-K/A · filed 2012-10-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRO DEX INC (PDEX)United States$0.234B13.64
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Profound Medical Corp. (PROF)$0.206B-7.37
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32